Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Turnover Ratios
Average No. Days
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The company exhibits a notable degradation in inventory efficiency and a significant extension of the cash conversion cycle between 2018 and 2022. While receivables management has remained consistent, the substantial increase in inventory holding times has lengthened the operating cycle, negatively impacting the speed at which cash is recovered from operations.
- Inventory Management
- A consistent downward trend in inventory turnover is observed, declining from 9.32 in 2018 to 3.25 in 2022. This is mirrored by the average inventory processing period, which expanded from 39 days to 112 days. This suggests a slowing movement of goods and an increase in the duration that capital is tied up in inventory.
- Receivables Management
- The receivables turnover remained relatively stable over the analyzed period, fluctuating within a narrow range between 3.76 and 4.48. The average receivable collection period showed minimal variance, moving from 81 days in 2018 to 84 days in 2022, indicating a steady and predictable collection process.
- Payables and Working Capital Efficiency
- Payables turnover demonstrated volatility, dropping to a low of 4.99 in 2020 before rising to 8.61 by 2022. The average payables payment period peaked at 73 days in 2020 but contracted to 42 days in 2022, suggesting a return to more rapid payment cycles. Conversely, the working capital turnover ratio showed a strong upward trend, increasing from 3.22 to 7.49, indicating a higher volume of sales generated per unit of working capital.
- Operating and Cash Conversion Cycles
- The operating cycle lengthened significantly from 120 days in 2018 to 196 days in 2022, driven primarily by the deterioration in inventory turnover. Consequently, the cash conversion cycle increased from 75 days to 154 days, reflecting a substantial increase in the time elapsed between the outlay of cash for raw materials and the receipt of cash from sales.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Inventory Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of net revenues | 1,100,860) | 1,017,229) | 708,706) | 662,899) | 518,625) | |
| Inventories | 338,752) | 230,230) | 139,237) | 112,051) | 55,641) | |
| Short-term Activity Ratio | ||||||
| Inventory turnover1 | 3.25 | 4.42 | 5.09 | 5.92 | 9.32 | |
| Benchmarks | ||||||
| Inventory Turnover, Competitors2 | ||||||
| Abbott Laboratories | 3.10 | 3.59 | — | — | — | |
| Intuitive Surgical Inc. | 2.27 | 2.98 | — | — | — | |
| Medtronic PLC | 2.20 | 2.43 | — | — | — | |
| Inventory Turnover, Sector | ||||||
| Health Care Equipment & Services | 30.70 | 31.85 | — | — | — | |
| Inventory Turnover, Industry | ||||||
| Health Care | 7.85 | 7.90 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Inventory turnover = Cost of net revenues ÷ Inventories
= 1,100,860 ÷ 338,752 = 3.25
2 Click competitor name to see calculations.
An analysis of the operating activity ratios from 2018 to 2022 reveals a significant divergence between the growth of cost of net revenues and the accumulation of inventory, resulting in a consistent decline in efficiency regarding inventory management.
- Cost of Net Revenues
- A sustained upward trend is evident in the cost of net revenues, which increased from 518,625 thousand US dollars in 2018 to 1,100,860 thousand US dollars in 2022. This represents a growth of approximately 112% over the five-year period, indicating a steady expansion in the scale of operations.
- Inventory Accumulation
- Inventory levels have experienced an aggressive increase, rising from 55,641 thousand US dollars in 2018 to 338,752 thousand US dollars in 2022. The growth in inventory holdings significantly outpaced the growth in cost of revenues, with inventory levels increasing by roughly 509% during the same timeframe.
- Inventory Turnover Ratio
- The inventory turnover ratio demonstrates a continuous and sharp decline, falling from 9.32 in 2018 to 3.25 in 2022. This downward trajectory indicates that inventory is being held for longer periods before being sold. The reduction in the turnover rate suggests a diminishing efficiency in converting inventory into sales, as the rate of inventory buildup has far exceeded the rate of cost of revenue growth.
The combination of these trends points to a systemic shift in the operating cycle. While the company has expanded its revenue-generating activities, the disproportionate increase in inventory suggests either a strategic decision to build significant safety stocks or a decrease in the velocity of product movement, which has led to a weakened inventory turnover profile over the analyzed period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Receivables Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Net revenues | 3,734,635) | 3,952,584) | 2,471,941) | 2,406,796) | 1,966,492) | |
| Accounts receivable, net of allowance for doubtful accounts | 859,685) | 897,198) | 657,704) | 550,291) | 439,009) | |
| Short-term Activity Ratio | ||||||
| Receivables turnover1 | 4.34 | 4.41 | 3.76 | 4.37 | 4.48 | |
| Benchmarks | ||||||
| Receivables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 7.02 | 6.64 | — | — | — | |
| Elevance Health Inc. | 18.81 | 20.66 | — | — | — | |
| Intuitive Surgical Inc. | 6.60 | 7.30 | — | — | — | |
| Medtronic PLC | 5.71 | 5.51 | — | — | — | |
| UnitedHealth Group Inc. | 18.22 | 20.07 | — | — | — | |
| Receivables Turnover, Sector | ||||||
| Health Care Equipment & Services | 14.33 | 14.76 | — | — | — | |
| Receivables Turnover, Industry | ||||||
| Health Care | 8.22 | 8.00 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Receivables turnover = Net revenues ÷ Accounts receivable, net of allowance for doubtful accounts
= 3,734,635 ÷ 859,685 = 4.34
2 Click competitor name to see calculations.
Between 2018 and 2022, net revenues exhibited a strong upward trajectory, increasing from approximately $1.97 billion to $3.73 billion. This growth was accompanied by a corresponding increase in net accounts receivable, which rose from $439 million in 2018 to $860 million by the end of 2022, indicating that credit extension scaled alongside sales expansion.
- Receivables Turnover Trend
- The receivables turnover ratio remained relatively stable over the five-year period, though it experienced a notable contraction in 2020, dropping to 3.76 from 4.37 in 2019. This decline indicates a temporary decrease in the efficiency of collecting outstanding receivables relative to the volume of sales generated during that fiscal year.
- Recovery and Stabilization
- A significant recovery in collection efficiency was observed in 2021, with the turnover ratio rising to 4.41. This improvement occurred despite a substantial surge in net revenues, which peaked at $3.95 billion in the same period. By 2022, the ratio stabilized at 4.34, suggesting that the company returned to its historical baseline of asset conversion efficiency.
- Operational Correlation
- The relationship between the growth in net revenues and the growth in accounts receivable suggests a disciplined approach to credit management. Because the turnover ratio returned to levels near the 2018 baseline (4.48) by 2022, it is evident that the company has successfully managed its receivables growth to prevent an undue accumulation of overdue accounts during its period of rapid scaling.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Payables Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of net revenues | 1,100,860) | 1,017,229) | 708,706) | 662,899) | 518,625) | |
| Accounts payable | 127,870) | 163,886) | 142,132) | 87,250) | 64,256) | |
| Short-term Activity Ratio | ||||||
| Payables turnover1 | 8.61 | 6.21 | 4.99 | 7.60 | 8.07 | |
| Benchmarks | ||||||
| Payables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.15 | 4.21 | — | — | — | |
| Elevance Health Inc. | 7.47 | 7.59 | — | — | — | |
| Intuitive Surgical Inc. | 13.78 | 14.45 | — | — | — | |
| Medtronic PLC | 4.46 | 4.98 | — | — | — | |
| UnitedHealth Group Inc. | 7.26 | 7.63 | — | — | — | |
| Payables Turnover, Sector | ||||||
| Health Care Equipment & Services | 6.94 | 7.18 | — | — | — | |
| Payables Turnover, Industry | ||||||
| Health Care | 5.79 | 5.84 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Payables turnover = Cost of net revenues ÷ Accounts payable
= 1,100,860 ÷ 127,870 = 8.61
2 Click competitor name to see calculations.
The payables turnover ratio exhibited a U-shaped trend between 2018 and 2022, characterized by a significant decline in the middle of the period followed by a strong recovery. The efficiency of payable settlements reached a low point in 2020 before accelerating to its highest level in 2022.
- Cost of Net Revenues Trend
- A consistent and substantial increase in the cost of net revenues is observed throughout the five-year period. Expenses grew from US$ 518.6 million in 2018 to US$ 1.1 billion in 2022, with a particularly sharp increase occurring between 2020 and 2021, indicating significant operational expansion.
- Accounts Payable Fluctuations
- Accounts payable followed a growth trajectory from 2018 to 2021, rising from US$ 64.3 million to a peak of US$ 163.9 million. However, 2022 marked a divergence where accounts payable decreased to US$ 127.9 million, despite the continued increase in the cost of net revenues.
- Payables Turnover Interpretation
- The payables turnover ratio declined from 8.07 in 2018 to 4.99 in 2020, suggesting a slowdown in payment frequency or an extension of credit terms granted by suppliers. Following 2020, the ratio trended upward, reaching 8.61 by the end of 2022. This movement indicates a strategic or operational shift toward faster settlement of supplier obligations, resulting in a higher turnover rate than that observed at the start of the analyzed period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Working Capital Turnover
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Current assets | 2,424,391) | 2,494,075) | 1,849,538) | 1,633,419) | 1,302,479) | |
| Less: Current liabilities | 1,925,887) | 1,924,071) | 1,325,601) | 970,970) | 692,073) | |
| Working capital | 498,504) | 570,004) | 523,937) | 662,449) | 610,406) | |
| Net revenues | 3,734,635) | 3,952,584) | 2,471,941) | 2,406,796) | 1,966,492) | |
| Short-term Activity Ratio | ||||||
| Working capital turnover1 | 7.49 | 6.93 | 4.72 | 3.63 | 3.22 | |
| Benchmarks | ||||||
| Working Capital Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.48 | 3.87 | — | — | — | |
| Elevance Health Inc. | 8.37 | 7.23 | — | — | — | |
| Intuitive Surgical Inc. | 1.29 | 1.22 | — | — | — | |
| Medtronic PLC | 2.97 | 2.15 | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | |
| Working Capital Turnover, Sector | ||||||
| Health Care Equipment & Services | 25.59 | 16.28 | — | — | — | |
| Working Capital Turnover, Industry | ||||||
| Health Care | 11.30 | 8.57 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Working capital turnover = Net revenues ÷ Working capital
= 3,734,635 ÷ 498,504 = 7.49
2 Click competitor name to see calculations.
The analysis of short-term operating activity from 2018 to 2022 reveals a significant increase in the efficiency with which working capital is utilized to generate net revenues. A consistent upward trajectory in the working capital turnover ratio indicates an optimized relationship between current assets and current liabilities relative to sales volume.
- Working Capital Turnover Trend
- The working capital turnover ratio experienced steady growth over the five-year period, rising from 3.22 in 2018 to 7.49 by the end of 2022. The most pronounced acceleration occurred between 2020 and 2021, where the ratio increased from 4.72 to 6.93. This trend suggests a substantial improvement in operational efficiency and a reduced reliance on a large base of working capital to support revenue growth.
- Revenue Growth Dynamics
- Net revenues grew substantially from 1,966,492 thousand US$ in 2018 to 3,734,635 thousand US$ in 2022. This growth was particularly aggressive between 2020 and 2021, when revenues surged from 2,471,941 thousand US$ to 3,952,584 thousand US$. The expansion of the top line acted as the primary driver for the rising turnover ratio.
- Working Capital Management
- Working capital remained relatively stable but showed a general downward trend, peaking at 662,449 thousand US$ in 2019 before declining to 498,504 thousand US$ in 2022. The combination of increasing net revenues and a decreasing working capital base created a compounding effect, further elevating the turnover ratio and indicating that the organization is generating more sales per dollar of working capital invested.
Overall, the data demonstrates a transition toward a more lean operating model. The capacity to generate nearly double the revenue in 2022 compared to 2018, while utilizing less working capital than was required at the start of the period, points to high operational leverage and efficient short-term asset management.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Inventory Processing Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Inventory turnover | 3.25 | 4.42 | 5.09 | 5.92 | 9.32 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average inventory processing period1 | 112 | 83 | 72 | 62 | 39 | |
| Benchmarks (no. days) | ||||||
| Average Inventory Processing Period, Competitors2 | ||||||
| Abbott Laboratories | 118 | 102 | — | — | — | |
| Intuitive Surgical Inc. | 161 | 122 | — | — | — | |
| Medtronic PLC | 166 | 150 | — | — | — | |
| Average Inventory Processing Period, Sector | ||||||
| Health Care Equipment & Services | 12 | 11 | — | — | — | |
| Average Inventory Processing Period, Industry | ||||||
| Health Care | 46 | 46 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 3.25 = 112
2 Click competitor name to see calculations.
Between 2018 and 2022, a consistent deterioration in inventory management efficiency is observed. The metrics indicate a systematic slowdown in the movement of goods through the operating cycle, characterized by a steady decline in turnover rates and a corresponding expansion of the time required to process inventory.
- Inventory Turnover
- A significant downward trend is evident, with the turnover ratio falling from 9.32 in 2018 to 3.25 in 2022. This decline indicates that the frequency with which inventory is sold and replaced has diminished substantially over the five-year period, suggesting a reduction in the velocity of inventory throughput.
- Average Inventory Processing Period
- The duration required to move inventory through the processing cycle has increased continuously, rising from 39 days in 2018 to 112 days in 2022. This represents a nearly threefold increase in the average time items remain in stock before being sold.
The inverse correlation between the declining turnover ratio and the increasing processing period highlights a growing inefficiency in short-term operating activity. The transition from a 39-day cycle to a 112-day cycle suggests potential challenges in demand alignment, an intentional increase in safety stock, or a slowing rate of sales relative to inventory accumulation.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Receivable Collection Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Receivables turnover | 4.34 | 4.41 | 3.76 | 4.37 | 4.48 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average receivable collection period1 | 84 | 83 | 97 | 83 | 81 | |
| Benchmarks (no. days) | ||||||
| Average Receivable Collection Period, Competitors2 | ||||||
| Abbott Laboratories | 52 | 55 | — | — | — | |
| Elevance Health Inc. | 19 | 18 | — | — | — | |
| Intuitive Surgical Inc. | 55 | 50 | — | — | — | |
| Medtronic PLC | 64 | 66 | — | — | — | |
| UnitedHealth Group Inc. | 20 | 18 | — | — | — | |
| Average Receivable Collection Period, Sector | ||||||
| Health Care Equipment & Services | 25 | 25 | — | — | — | |
| Average Receivable Collection Period, Industry | ||||||
| Health Care | 44 | 46 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 4.34 = 84
2 Click competitor name to see calculations.
The analysis of receivables activity from 2018 to 2022 reveals a period of relative stability punctuated by a temporary decline in collection efficiency during the 2020 fiscal year.
- Receivables Turnover Trends
- The receivables turnover ratio began at 4.48 in 2018, experiencing a gradual decline to 4.37 in 2019 before dropping to a five-year low of 3.76 in 2020. A recovery was observed in 2021 as the ratio rose to 4.41, followed by a slight stabilization to 4.34 by the end of 2022.
- Average Receivable Collection Period
- The average time required to collect receivables remained consistent at 81 days in 2018 and 83 days in 2019. A notable increase to 97 days occurred in 2020, representing a peak in the collection cycle. This duration subsequently normalized to 83 days in 2021 and 84 days in 2022, indicating a return to historical operational norms.
- Operational Correlation
- An inverse relationship between the turnover ratio and the collection period is evident throughout the observed timeframe. The spike in the collection period during 2020 indicates a temporary slowdown in the conversion of receivables into cash. The rapid correction in 2021 suggests that the factors causing the 2020 delay were transient, and the company successfully restored its credit collection efficiency to pre-2020 levels.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Operating Cycle
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 112 | 83 | 72 | 62 | 39 | |
| Average receivable collection period | 84 | 83 | 97 | 83 | 81 | |
| Short-term Activity Ratio | ||||||
| Operating cycle1 | 196 | 166 | 169 | 145 | 120 | |
| Benchmarks | ||||||
| Operating Cycle, Competitors2 | ||||||
| Abbott Laboratories | 170 | 157 | — | — | — | |
| Intuitive Surgical Inc. | 216 | 172 | — | — | — | |
| Medtronic PLC | 230 | 216 | — | — | — | |
| Operating Cycle, Sector | ||||||
| Health Care Equipment & Services | 37 | 36 | — | — | — | |
| Operating Cycle, Industry | ||||||
| Health Care | 90 | 92 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 112 + 84 = 196
2 Click competitor name to see calculations.
The operating cycle demonstrates a persistent upward trajectory over the five-year period ending December 31, 2022, indicating a lengthening of the time required to convert current assets into cash. The total cycle extended from 120 days in 2018 to 196 days in 2022, reflecting an overall increase in the working capital commitment required to support operations.
- Average Inventory Processing Period
- A significant and continuous increase is observed in the time required to process inventory. The period rose from 39 days in 2018 to 112 days by 2022. This steady escalation suggests a decline in inventory turnover efficiency or a strategic decision to maintain higher stock levels, and it serves as the primary catalyst for the expansion of the total operating cycle.
- Average Receivable Collection Period
- The collection of receivables remained relatively stable throughout the analyzed timeframe. Excluding a temporary peak of 97 days in 2020, the period consistently hovered between 81 and 84 days. This pattern indicates that the efficiency of credit and collection processes has remained constant, independent of the changes seen in inventory management.
- Operating Cycle Analysis
- The expansion of the operating cycle is almost entirely attributable to the lengthening inventory processing period. The overall increase of 76 days in the operating cycle closely correlates with the 73-day increase in inventory processing time. Consequently, the increase in the duration of the operating cycle is driven by internal inventory accumulation rather than a slowdown in customer payment behaviors.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Payables Payment Period
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Payables turnover | 8.61 | 6.21 | 4.99 | 7.60 | 8.07 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average payables payment period1 | 42 | 59 | 73 | 48 | 45 | |
| Benchmarks (no. days) | ||||||
| Average Payables Payment Period, Competitors2 | ||||||
| Abbott Laboratories | 88 | 87 | — | — | — | |
| Elevance Health Inc. | 49 | 48 | — | — | — | |
| Intuitive Surgical Inc. | 26 | 25 | — | — | — | |
| Medtronic PLC | 82 | 73 | — | — | — | |
| UnitedHealth Group Inc. | 50 | 48 | — | — | — | |
| Average Payables Payment Period, Sector | ||||||
| Health Care Equipment & Services | 53 | 51 | — | — | — | |
| Average Payables Payment Period, Industry | ||||||
| Health Care | 63 | 63 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 8.61 = 42
2 Click competitor name to see calculations.
The financial data indicates a fluctuating cycle in the management of accounts payable from 2018 through 2022. A notable deviation occurred in 2020, where the efficiency of payables turnover reached its lowest point, coinciding with the longest payment duration. Since 2020, there has been a consistent trend toward faster payment cycles and higher turnover rates.
- Payables Turnover Trends
- The payables turnover ratio decreased from 8.07 in 2018 to 7.60 in 2019, before dropping sharply to 4.99 in 2020. A recovery phase followed, with the ratio rising to 6.21 in 2021 and peaking at 8.61 in 2022. This progression suggests a transition from slower to more rapid liquidation of short-term liabilities.
- Average Payables Payment Period Analysis
- The average payment period mirrored the turnover trends, increasing from 45 days in 2018 to 48 days in 2019, and spiking to 73 days in 2020. This peak represents a significant extension of the credit period utilized. Following this peak, the period contracted to 59 days in 2021 and reached its lowest level of 42 days in 2022, indicating an improved capacity or preference for prompt supplier settlement.
Overall, the data demonstrates a return to, and subsequent improvement upon, pre-2020 operating efficiency regarding payables management. The reduction of the payment period to 42 days by the end of 2022 signifies a more aggressive payment strategy compared to the historical average observed between 2018 and 2021.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Cash Conversion Cycle
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 112 | 83 | 72 | 62 | 39 | |
| Average receivable collection period | 84 | 83 | 97 | 83 | 81 | |
| Average payables payment period | 42 | 59 | 73 | 48 | 45 | |
| Short-term Activity Ratio | ||||||
| Cash conversion cycle1 | 154 | 107 | 96 | 97 | 75 | |
| Benchmarks | ||||||
| Cash Conversion Cycle, Competitors2 | ||||||
| Abbott Laboratories | 82 | 70 | — | — | — | |
| Intuitive Surgical Inc. | 190 | 147 | — | — | — | |
| Medtronic PLC | 148 | 143 | — | — | — | |
| Cash Conversion Cycle, Sector | ||||||
| Health Care Equipment & Services | -16 | -15 | — | — | — | |
| Cash Conversion Cycle, Industry | ||||||
| Health Care | 27 | 29 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 112 + 84 – 42 = 154
2 Click competitor name to see calculations.
The cash conversion cycle exhibits a significant upward trajectory over the analyzed five-year period, expanding from 75 days in 2018 to 154 days by the end of 2022. This trend indicates a substantial increase in the time required to convert resource inputs into cash flows from sales, suggesting a decline in overall working capital efficiency.
- Average Inventory Processing Period
- A consistent and sharp increase is observed in the time required to process inventory. The period rose from 39 days in 2018 to 112 days in 2022. This steady climb suggests a buildup of inventory or a deceleration in inventory turnover, acting as the primary driver for the expansion of the total cash conversion cycle.
- Average Receivable Collection Period
- The collection of receivables remained relatively stable throughout the period. While a peak of 97 days occurred in 2020, the duration returned to 84 days by 2022, remaining close to the initial 81 days reported in 2018. This suggests that credit and collection policies have remained largely consistent.
- Average Payables Payment Period
- The payables payment period showed volatility, peaking at 73 days in 2020 before contracting to 42 days in 2022. The reduction in the payment period toward the end of the sequence indicates that obligations to suppliers are being settled more rapidly, which further accelerates the cash outflow and contributes to the lengthening of the cash conversion cycle.
The acceleration of the cash conversion cycle is particularly pronounced in 2022, where the cycle jumped from 107 to 154 days. This deterioration is the result of a compounding effect: a continued increase in inventory holding times combined with a significant reduction in the period allowed for paying suppliers.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?